Literature DB >> 21827916

Spinocerebellar ataxia type 20.

Elsdon Storey1, R J McKinlay Gardner.   

Abstract

Spinocerebellar ataxia type 20 (SCA20), first reported in 2004, is a slowly progressive dominantly inherited disorder so far reported in a single Anglo-Celtic family from Australia. It is characterized by dentate calcification from an early stage of the illness. Dysarthria without ataxia is the first symptom in the majority - an unusual feature amongst the SCAs. In addition to ataxia, examination often reveals spasmodic dysphonia and palatal tremor, but the syndrome is otherwise fairly pure. The responsible genetic abnormality has been tentatively identified as a 260-kb duplication in the pericentric region of chromosome 11, but confirmation will necessarily await description of further families. 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21827916     DOI: 10.1016/B978-0-444-51892-7.00038-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  4 in total

Review 1.  The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability.

Authors:  Katherine E Hekman; Christopher M Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-18       Impact factor: 10.154

2.  Very late-onset friedreich ataxia with laryngeal dystonia.

Authors:  Silvia Rota; Eleonora Marchina; Alice Todeschini; Lorenzo Nanetti; Fabrizio Rinaldi; Alessandra Vanotti; Caterina Mariotti; Alessandro Padovani; Massimiliano Filosto
Journal:  Case Rep Neurol       Date:  2014-12-12

3.  Palatal Tremor - Pathophysiology, Clinical Features, Investigations, Management and Future Challenges.

Authors:  Shakya Bhattacharjee
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-10-08

Review 4.  Spinocerebellar ataxia type 23 (SCA23): a review.

Authors:  Fan Wu; Xu Wang; Xiaohan Li; Huidi Teng; Tao Tian; Jing Bai
Journal:  J Neurol       Date:  2020-11-11       Impact factor: 6.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.